Response to letter re: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression

Eur J Cancer. 2021 Nov:157:523-524. doi: 10.1016/j.ejca.2021.07.044. Epub 2021 Sep 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • B7-H1 Antigen
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors
  • Lung Neoplasms* / drug therapy

Substances

  • Anti-Bacterial Agents
  • B7-H1 Antigen
  • Immune Checkpoint Inhibitors